Dermata Therapeutics, Inc. Warrant - stock earnings
DRMAW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.7 million USD | ? USD |
| 2023Q2 | -1.7 million USD | ? USD |
| 2023Q1 | -2.2 million USD | ? USD |
| 2022Q4 | -1.6 million USD | ? USD |
| 2022Q3 | -2.4 million USD | ? USD |
| 2022Q2 | -2.7 million USD | ? USD |
| 2022Q1 | -2.8 million USD | ? USD |
| 2021Q4 | -2.6 million USD | ? USD |
| 2021Q3 | -1.7 million USD | ? USD |
| 2021Q2 | -1.3 million USD | ? USD |
| 2021Q1 | -2.3 million USD | ? USD |
| 2020Q4 | -396313 USD | ? USD |
| 2020Q3 | -597395 USD | ? USD |
| 2020Q2 | -821649 USD | ? USD |
| 2020Q1 | -1.4 million USD | ? USD |
DRMAW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.3 million USD | ? USD |
| 2022 | -9.6 million USD | ? USD |
| 2021 | -7.9 million USD | ? USD |
| 2020 | -3.4 million USD | ? USD |
| 2019 | -5.0 million USD | ? USD |
DRMAW
Price: $0.02
52 week price:
Earnings Per Share: -2.16 USD
P/E Ratio: -0.01
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 203
Market Capitalization: 1.3 million